Hudson Canyon Capital Management’s Merck MRK Stock Holding History

Hudson Canyon Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,500	Closed	-$1.54M	–	56
2024 Q4	$1.54M	Hold	15,500	–	–	1.01%	53
2024 Q3	$1.76M	Buy	15,500 +1,848	+14%	+$220K	1.14%	47
2024 Q2	$1.69M	Sell	13,652 -1,848	-12%	-$238K	1.14%	38
2024 Q1	$2.05M	Hold	15,500	–	–	1.32%	34
2023 Q4	$1.69M	Hold	15,500	–	–	1.23%	47
2023 Q3	$1.6M	Hold	15,500	–	–	1.31%	41
2023 Q2	$1.79M	Buy	+15,500	New	+$1.76M	1.41%	34
2021 Q2	–	Sell	-20,729	Closed	-$1.52M	–	60
2021 Q1	$1.52M	Buy	20,729 +815	+4%	+$60.1K	1.2%	57
2020 Q4	$1.55M	Buy	+19,914	New	+$1.52M	1.24%	51

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudson Canyon Capital Management's MRK Position: Q1 2025 in Review

Hudson Canyon Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 15,500 shares — an estimated $1.54M sold.

Hudson Canyon Capital Management first reported a position in MRK in Q4 2020 and held it in 9 quarters. The position peaked at $2.05M in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Hudson Canyon Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Hudson Canyon Capital Management sold 15,500 Merck shares in Q1 2025, an estimated $1.54M.
Hudson Canyon Capital Management first reported a position in Merck in Q4 2020 and held it in 9 quarters.
Hudson Canyon Capital Management's Merck position peaked at $2.05M in Q1 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Hudson Canyon Capital Management's 13F filing for Q1 2025, filed 12 May 2025.